Overview
PEPS ranks this pair inside the Top 300 market-cap universe. That means Injective and AKT are liquid enough for an indexable comparison, with metrics refreshed on the hourly coin pipeline.
Quick winners
Full comparison
| Metric | INJ | AKT |
|---|---|---|
| Price | $4.99 | $1,861.70 |
| Market Cap | $490.41M | $138.93M |
| FDV | — | — |
| Volume 24h | $2.65M | $4.50M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 99.00 | 208.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.97% | +3.64% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | INJ | AKT |
|---|---|---|
| 1H | — | — |
| 24H | +1.03% | -0.90% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | INJ | AKT |
|---|---|---|
| RSI | 49.29 | 49.02 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.29 | 67.35 |
| ADX | 12.19 | 21.33 |
| Support | 4.91 | 1,827.82 |
| Resistance | 5.07 | 1,960.30 |
| Trend | neutral | bearish |
| Momentum | — | 65.00 |
| Signal | neutral | neutral |
Automatic technical analysis
Indicator stacks for INJ/AKT currently lean on separate regimes: neutral versus bearish. Treat MACD and RSI as context, not as standalone entry triggers.
Fundamentals
| Metric | INJ | AKT |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 0.00 | — |
| Github activity | 118.00 | — |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Injective
AKT
Pros and cons
Pros of Injective
- Higher ranking for Injective can translate into tighter spreads on major venues.
- Injective typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
- Composite PEPS readings for Injective can surface clearer module agreement during trend phases.
Cons of Injective
- Large-cap status for Injective can mean slower percentage upside versus high-beta alternatives.
- Crowded positioning around INJ sometimes amplifies squeeze or flush risk.
- When dominance narratives fade, Injective can lag hotter rotation names.
Pros of AKT
- Active volume bursts on AKT sometimes precede sharper tactical moves.
- Diversifying versus Injective with AKT can change portfolio factor exposure.
- PEPS tracking for AKT still includes AI score and level context for monitoring.
- Narrative optionality around AKT can reprice quickly when catalysts appear.
Cons of AKT
- Smaller book depth versus large caps can increase slippage for AKT.
- Weaker market-cap standing may leave AKT more exposed to liquidity droughts.
- Higher volatility on AKT cuts both ways and demands stricter risk limits.
- Trend failures on AKT often travel faster than on more established assets.
Which looks stronger right now?
Data currently points to a probabilistic edge for Injective on size and AKT on activity. Neither reading guarantees future returns.
AI summary
Comparing INJ and AKT begins with structure: capitalization, volume and rank. Present prints are $4.99 versus $1,861.70. Momentum and trend can disagree with market-cap hierarchy. That is normal in crypto rotations and should be stress-tested against supports and news flow. Canonical URLs prevent duplicate AKT-vs-INJ pages, keeping SEO equity on one comparison. Keep monitoring winners as data updates.
FAQ
Which is better, Injective or AKT?
“Better” depends on horizon and risk. Injective leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, INJ or AKT?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Injective and AKT.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. AKT currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.